These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25743673)

  • 1. [Optimizing antihypertensive therapy].
    Schlimpert V
    MMW Fortschr Med; 2015 Feb; 157(3):66. PubMed ID: 25743673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension. Goal: achieving target blood pressure with only 1 pill daily].
    MMW Fortschr Med; 2013 Apr; 155(6):66-7. PubMed ID: 23700703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertension. Guidelines recommend fixed combinations].
    MMW Fortschr Med; 2014 Apr; 156(7):62-3. PubMed ID: 24956662
    [No Abstract]   [Full Text] [Related]  

  • 4. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 'pyrrhic victory' of amlodipine over hydrochlorothiazide in the OLAS Study.
    Thomopoulos C; Tsioufis C; Makris T; Stefanadis C
    J Hum Hypertens; 2011 Jun; 25(6):401-2; author reply 403-4. PubMed ID: 21368776
    [No Abstract]   [Full Text] [Related]  

  • 6. Olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide triple combination for hypertension.
    Ram CV
    Expert Rev Cardiovasc Ther; 2011 Jan; 9(1):9-19. PubMed ID: 21166525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine + valsartan + hydrochlorothiazide. A 3-drug fixed-dose combination for hypertension: too many drawbacks.
    Prescrire Int; 2011 Mar; 20(114):67. PubMed ID: 21648225
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
    Tocci G; Paneni F; Passerini J; Volpe M
    Expert Opin Pharmacother; 2012 Dec; 13(18):2687-97. PubMed ID: 23170911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors.
    McInnes GT
    J Hum Hypertens; 2011 Jun; 25(6):343-5. PubMed ID: 21390054
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effective blood pressure control with a fixed combination].
    Bäurle A
    MMW Fortschr Med; 2016 May; 158(10):84. PubMed ID: 27221444
    [No Abstract]   [Full Text] [Related]  

  • 11. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 12. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
    J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA; Shojaee A; Maa JF; Neutel JM
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From the beginning -- a strong-acting and well tolerable antihypertensive agent. The recipe against constant change].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963998
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.